Full Text
PRO15 ORPHAN DRUG METHODOLOGY CHALLENGES IN THE DANISH HTA PROCESS - MEDICINRAADET AND THE HURDLES TO SHOWING CLINICAL BENEFIT IN SMALL PATIENT POPULATIONS

Abstract

Authors

U. Ploug A.B. Moerch

Back to Volume 22, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×